Effects of Advanced Trauma Life Support® on Adult Trauma Patient Outcomes
ADVANCE TRAUMA
1 other identifier
interventional
4,320
1 country
10
Brief Summary
Rationale: Trauma is a massive global health issue. Many training programmes have been developed to help physicians in the initial management of trauma patients. Among these programmes, Advanced Trauma Life Support® (ATLS®) is the most popular, having trained over one million physicians worldwide. Despite its widespread use, there are no controlled trials showing that ATLS® improves patient outcomes. Multiple systematic reviews emphasise the need for such trials. Aim: To compare the effects of ATLS® training with standard care on outcomes in adult trauma patients. Trial Population: Adult trauma patients presenting to the emergency department of a participating hospital. Eligibility Criteria: Hospitals are secondary or tertiary hospitals in India that admit or refer/transfer for admission at least 400 patients with trauma per year. Clusters are one or more units of physicians providing initial trauma care in the emergency department of tertiary hospitals in India. Patients participants are adult trauma patients who presents to the emergency department of participating hospitals and are admitted or transferred for admission. Ethical Considerations: The study will use an opt-out consent approach for in-hospital collection of routinely recorded data, in which consent is presumed unless actively declined. Informed consent for non-routinely recorded data including out of hospital follow up will be obtained. Patients who are unconscious or lack a legally authorized representative will be included under a waiver of informed consent. Note that consent here refers to consent to data collection, as it will not be possible for patients to opt out from being subjected to the intervention. This approach is justified because the trial can be considered to involve only minimal risk and the data collection is non-invasive and mostly involve extracting routinely collected data from medical records. Funding: Swedish Research Council (reg. no. 2023-03128), Laerdal Foundation (reg. no. 2023-0297). Special considerations: This trial is not yet fully funded. The Trial Management Group has decided to proceed with the trial with the expectation that additional funding will be secured. The Joint Trial Steering and Data Monitoring Committee will be informed of the funding status at each meeting. If funding is not secured, the trial will be stopped. This will likely result in an underpowered trial. The justification for this decision is that the intervention is considered standard of care in many countries and the data collection is considered minimal risk. There is therefore a very small risk of harm to patient participants, but a potential direct benefit to those.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Longer than P75 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedStudy Start
First participant enrolled
February 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2029
January 23, 2026
January 1, 2026
4.7 years
March 14, 2024
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In-hospital mortality within 30 days of arrival at the emergency department
Clinical research coordinators will extract information on death from patient hospital records. If the patient has been transferred to another hospital, the clinical research coordinators will collect data on this outcome by calling the patient or a patient representative, or by contacting the hospital to which the patient was transferred. Data on this outcome will be collected continuously during the trial.
30 days
Study Arms (2)
Advanced Trauma Life Support
EXPERIMENTALThe intervention will be ATLS® training, a proprietary 2.5 day course teaching a standardised approach to trauma patient care using the concepts of a primary and secondary survey. Physicians will be trained in an accredited ATLS® training facility in India.
Standard care
NO INTERVENTIONStandard care varies across hospitals in India, but trauma patients are initially managed by casualty medical officers, surgical residents, or emergency medicine residents. They are mainly first- or second-year residents who resuscitate patients, perform interventions and refer patients for imaging or other investigations. Compared with other settings where a trauma team approach is adopted, nurses and other healthcare professionals are only involved to a limited extent during the initial management.
Interventions
Advanced Trauma Life Support (ATLS) is a proprietary 2.5 day course teaching a standardised approach to trauma patient care using the concepts of a primary and secondary survey. The programme was developed by the Committee of Trauma of the American College of Surgeons. The course includes intial treatment and resuscitation, triage and interfacility transfers. Leaning is based on practical scenario-driven skill stations, lectures and includes a final performance proficiency evaluation. Physicians will be trained in an accredited ATLS training facility in India.
Eligibility Criteria
You may qualify if:
- age of at least 15 years;
- trauma occurred less than 48 hours before arrival at the hospital;
- present to the emergency department of participating hospitals, with a history of trauma defined as having any of the reasons listed in the International Classification of Diseases chapter XX as the reason for presenting;
- admitted or died between arrival at the hospital and admission, or referred/transferred from the emergency department of a participating hospital to another hospital for admission; and
- managed by a participating cluster in the emergency department.
You may not qualify if:
- present with isolated limb injuries; or
- are directly admitted to a ward without being seen by a physician in the emergency department.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- The George Institutecollaborator
Study Sites (10)
Assam Medical College & Hospital
Dibrugarh, Assam, 786003, India
KEM Hospital
Mumbai, Maharashtra, 400012, India
Lokmanya Tilak Municipal General Hospital
Mumbai, Maharashtra, 400022, India
Hridaysamrat Balasaheb Thackre Mun. Medical college and Dr. R.N. Cooper Hospital
Mumbai, Maharashtra, 400056, India
Holy Family Hospital
New Delhi, New Delhi, 110025, India
Dayanand Medical College & Hospital
Ludhiana, Punjab, 141001, India
Christian Medical College & Hospital
Ludhiana, Punjab, 141008, India
Himalayan Institute of Medical Sciences, Swami Rama Himalayan University
Dehradun, Uttarakhand, 248016, India
Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital (IPGMER and SSKM Hospital)
Kolkata, West Bengal, 700020, India
Government Medical College Hospital
Chandigarh, 160030, India
Related Publications (1)
Ranjan S, Falth S, Kharat P, Bassi A, Bakhshi GD, Basak D, Berg J, Chatterjee S, Fellander-Tsai L, Hemming K, Jha V, Kasza J, Khajanchi M, Martin J, Mishra A, Olofsson A, Roy N, Singh R, Soni KD, Gerdin Warnberg M. Effects of Advanced Trauma Life Support(R) training compared with standard care on adult trauma patient outcomes (ADVANCE TRAUMA): study protocol for a stepped-wedge cluster randomised trial. Trials. 2026 Feb 3;27(1):176. doi: 10.1186/s13063-026-09491-z.
PMID: 41630085DERIVED
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Researcher
Study Record Dates
First Submitted
March 14, 2024
First Posted
March 20, 2024
Study Start
February 27, 2025
Primary Completion (Estimated)
November 1, 2029
Study Completion (Estimated)
November 1, 2029
Last Updated
January 23, 2026
Record last verified: 2026-01